I read through the 10-K myself, and this share price already basically reflects the contents, given its 52-week high. I'm seeing this as a great buying opportunity at bargain basement prices, especially given the legislation getting pushed through Congress. Once medical cannabis is reduced to Schedule 2 status, the lid is going to blow off this baby like a loose pressure cooker lid, at least in my opinion. This sector is our big chance to make serious coin, IMO, and this company has a solid cadre of scientific professionals to make it a serious contender.
GLTY.
